Historical record - last NADAC effective date: 1/17/2018
Product Information
CEFIXIME 200 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $5.6934 per ML under NDC 68180040704. Its NADAC has been published 123 times since Apr 20, 2016.
FDA first approved this application on Apr 10, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040704
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
1/17/2018
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA065355FDA Approved
4/10/2007
TE Code
AB
On Market Since
4/24/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 200 MG/5 ML SUSP has been published 123 times since Apr 20, 2016, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6934 per ML |
|---|---|
| All-time high | $6.3066 (Aug 10, 2016) |
| All-time low | $5.6934 (Jan 17, 2018) |
| Median price | $6.1240 |
| Average price | $5.9637 |
| Largest weekly change | -7.0% (Jan 17, 2018) |
| Weeks tracked | 123 |
| Tracking since | Apr 20, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.7%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CEFIXIME market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFIXIME 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 200 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $5.6934 per ML (NDC 68180040704), effective Jan 16, 2019.
How has the price of CEFIXIME 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 200 MG/5 ML SUSP has declined 9.7%. It has been tracked across 123 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for CEFIXIME 200 MG/5 ML SUSP?
Since Apr 20, 2016, the NADAC for CEFIXIME 200 MG/5 ML SUSP has ranged from a low of $5.6934 (Jan 17, 2018) to a high of $6.3066 (Aug 10, 2016), with a median of $6.1240 per ML.
Are there cheaper alternatives to CEFIXIME 200 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFIXIME 200 MG/5 ML SUSP, is $3.4266 per ML — about 40% below CEFIXIME 200 MG/5 ML SUSP.
Who manufactures CEFIXIME 200 MG/5 ML SUSP?
CEFIXIME 200 MG/5 ML SUSP (NDC 68180040704) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.